REPLIGEN CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that REPLIGEN CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $41.61M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | $36.58M | Feb 22, 2018 |
| FY2017 | Jun 30, 2017 | $32.46M | Feb 22, 2018 |
| FY2017 | Mar 31, 2017 | $30.59M | Feb 22, 2018 |
| FY2017 | Dec 31, 2016 | $25.60M | Feb 22, 2018 |
| FY2017 | Sep 30, 2016 | $24.68M | Feb 22, 2018 |
| FY2017 | Jun 30, 2016 | $29.17M | Feb 22, 2018 |
| FY2017 | Mar 31, 2016 | $25.09M | Feb 22, 2018 |
| FY2016 | Dec 31, 2015 | $21.45M | Feb 23, 2017 |
| FY2016 | Sep 30, 2015 | $19.81M | Feb 23, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.89M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($25.51M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $35.60M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $185.96M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $128.29M | Nov 18, 2024 |
| FY2020 | Dec 31, 2020 | $19.70M | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | $14.55M | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | $15.86M | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | $9.82M | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | $3.60M | Feb 24, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $55.17M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | ($35.11M) | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $47.70M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $224.67M | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | $167.25M | Nov 18, 2024 |
| FY2022 | Dec 31, 2020 | $69.82M | Feb 22, 2023 |
| FY2021 | Dec 31, 2019 | $36.08M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $25.99M | Feb 24, 2021 |
| FY2017 | Dec 31, 2017 | $3.26M | Feb 22, 2018 |
| FY2017 | Sep 30, 2017 | ($406.0K) | Feb 22, 2018 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.95B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.83B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.83B | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $2.53B | Nov 18, 2024 |
| FY2022 | Dec 31, 2021 | $2.36B | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $1.90B | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $1.40B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $774.62M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $743.52M | Mar 1, 2019 |
| FY2017 | Dec 31, 2016 | $288.91M | Feb 22, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $843.57M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $856.95M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $866.34M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $620.90M | Nov 18, 2024 |
| FY2022 | Dec 31, 2021 | $608.29M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $373.74M | Feb 17, 2022 |
| FY2020 | Dec 31, 2019 | $340.35M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $159.05M | Feb 26, 2020 |
| FY2018 | Dec 31, 2017 | $151.97M | Mar 1, 2019 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.11B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $1.97B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $1.96B | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $1.91B | Feb 26, 2026 |
| FY2024 | Dec 31, 2021 | $1.75B | Mar 14, 2025 |
| FY2023 | Dec 31, 2020 | $1.53B | Nov 18, 2024 |
| FY2022 | Dec 31, 2019 | $1.06B | Feb 22, 2023 |
| FY2021 | Dec 31, 2018 | $615.57M | Feb 17, 2022 |
| FY2020 | Dec 31, 2017 | $591.55M | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $168.76M | Feb 26, 2020 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Nov 18, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 24, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Mar 14, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Nov 18, 2024 |
| FY2020 | Dec 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Sep 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Jun 30, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Mar 31, 2020 | 0 | Feb 24, 2021 |
| FY2020 | Dec 31, 2019 | 0 | Feb 24, 2021 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $566.02M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $757.36M | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $751.32M | Mar 14, 2025 |
| FY2023 | Dec 31, 2022 | $523.46M | Nov 18, 2024 |
| FY2022 | Dec 31, 2021 | $603.81M | Feb 22, 2023 |
| FY2021 | Dec 31, 2020 | $717.29M | Feb 17, 2022 |
| FY2021 | Dec 31, 2019 | $528.39M | Feb 17, 2022 |
| FY2020 | Dec 31, 2018 | $193.82M | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $173.76M | Feb 26, 2020 |
| FY2018 | Dec 31, 2016 | $122.23M | Mar 1, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $542.21M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $525.57M | Feb 26, 2026 |